Kisspeptin · research summary

Therapeutic potential of nasal kisspeptin-54 for reducing α-synuclein accumulation and restoring hippocampal synaptic plasticity in a 6-hydroxydopamine-induced rat model of Parkinson's disease.

Turkish journal of medical sciences · 2026. Summary drawn from the study's full text. Each statement is followed by the exact sentence it comes from. This is a research summary, not medical advice.

Study type

Preclinical animal study using a 6-OHDA rat model of Parkinson's disease
“This study aimed to evaluate the therapeutic efficacy of chronic nasal KP-54 administration in a 6-hydroxydopamine (6-OHDA) rat model of PD, focusing on motor and cognitive outcomes, hippocampal synaptic plasticity, and α-syn pathology.”

Subjects

Adult male Sprague–Dawley rats
“A total of 24 adult male Sprague–Dawley rats (3 months old) were used in this study.”

Sample size

24 rats total, with 8 per group for behavioral assessments, 5 per group for LTP recordings, and 3 per group for immunofluorescence
“In each experimental group, eight animals were used for behavioral assessments; thereafter, five animals per group were allocated to hippocampal LTP recordings, whereas the remaining three animals per group were processed for immunofluorescence analyses.”

Duration

6 weeks total, with treatment administered daily for 3 weeks starting 3 weeks after lesion induction
“Subsequently, from weeks 3 to 6, animals in the 6-OHDA + KP-54 group received daily nasal administration of KP-54 (3 nmol/kg/day) for 3 weeks to evaluate its therapeutic effects.”

Reported findings

Chronic nasal KP-54 administration improved motor deficits and cognitive performance in 6-OHDA-lesioned rats
“Chronic nasal KP-54 significantly ameliorated motor and cognitive deficits induced by 6-OHDA.”
KP-54 treatment restored hippocampal synaptic plasticity as measured by LTP
“KP-54 restored hippocampal synaptic plasticity, enhanced the survival of tyrosine hydroxylase-positive dopaminergic neurons, and reduced α-syn accumulation in both the substantia nigra and hippocampus.”
KP-54 increased the survival of dopaminergic neurons and reduced α-synuclein accumulation
“Nasal KP-54 administration significantly increased the number of TH-positive neurons (64.11 ± 2.34 cells, p < 0.05, n = 3) compared with the 6-OHDA group.”

Limitations stated by the authors

Synaptic plasticity was assessed only functionally without structural or molecular analyses, and gene expression could not be evaluated due to budgetary constraints
“A limitation of this study is that synaptic plasticity was assessed only functionally, without structural or molecular analyses. In addition, the inability to evaluate gene expression due to budgetary constraints constitutes another limitation of the present study.”

Source: PubMed 42676968 · DOI 10.55730/1300-0144.6376 · all study summaries

Study type

Preclinical animal study using a 6-OHDA rat model of Parkinson's disease

“This study aimed to evaluate the therapeutic efficacy of chronic nasal KP-54 administration in a 6-hydroxydopamine (6-OHDA) rat model of PD, focusing on motor and cognitive outcomes, hippocampal synaptic plasticity, and α-syn pathology.”

Sample size

24 rats total, with 8 per group for behavioral assessments, 5 per group for LTP recordings, and 3 per group for immunofluorescence

“In each experimental group, eight animals were used for behavioral assessments; thereafter, five animals per group were allocated to hippocampal LTP recordings, whereas the remaining three animals per group were processed for immunofluorescence analyses.”

Reported findings

Chronic nasal KP-54 administration improved motor deficits and cognitive performance in 6-OHDA-lesioned rats

“Chronic nasal KP-54 significantly ameliorated motor and cognitive deficits induced by 6-OHDA.”

KP-54 treatment restored hippocampal synaptic plasticity as measured by LTP

“KP-54 restored hippocampal synaptic plasticity, enhanced the survival of tyrosine hydroxylase-positive dopaminergic neurons, and reduced α-syn accumulation in both the substantia nigra and hippocampus.”

KP-54 increased the survival of dopaminergic neurons and reduced α-synuclein accumulation

“Nasal KP-54 administration significantly increased the number of TH-positive neurons (64.11 ± 2.34 cells, p < 0.05, n = 3) compared with the 6-OHDA group.”

Limitations stated by the authors

Synaptic plasticity was assessed only functionally without structural or molecular analyses, and gene expression could not be evaluated due to budgetary constraints

“A limitation of this study is that synaptic plasticity was assessed only functionally, without structural or molecular analyses. In addition, the inability to evaluate gene expression due to budgetary constraints constitutes another limitation of the present study.”